Tim Wilson, PhD.
Chief Executive Officer
Tim’s career in the life sciences has encompassed start ups, venture capital, investment banking and equity research. He has held senior positions at a number of firms including
Chief Scientific Officer
Kevin began his career in the biotechnology industry at Cambridge Antibody Technology (now part of Medimmune, an AstraZeneca company) when CAT was still in its start-up phase. He
Chief Financial Officer
Nick brings over 30 years of experience in fundraising, public markets and private equity, gained through financial and commercial roles in international pharmaceuticals and technology businesses. Most recently,
VP of Product Development
Leanne has over 20 years’ experience developing therapeutics from bench to clinic. She has worked as a scientist to develop vaccines at the Defence Science and Technology Laboratory
VP of Clinical Operations
Andrew has over 25 years of experience in the life sciences industry, holding management and executive positions in both the CRO and biotechnology sector, supporting pharmaceutical development. Andrew
VP of Biology
Elizabeth has more than 15 years’ experience in the pharmaceutical industry. Most recently, Elizabeth was a Senior Director at AstraZeneca leading a team supporting preclinical research in Oncology.